#JapanStock

List of IR information related to "JapanStock".

4,840 IR Posts
5 Companies
20672 days ago Last Updated

Filters

Reset
Period:
Importance:
4840 IR Posts
3070 Jelly Beans Group Co., Ltd.
2026/08/08
Notice of Conclusion of Exclusive Distribution Agency Agreement for the “iHEAL” Brand in Japan

Entered into an exclusive domestic distribution agreement for the Korean femcare brand “iHEAL.” Jelly Beans will serve as the Japanese master distributor, aiming for full-scale sales in the second half of 2027 through direct sales, wholesale, and online channels. Also presenting brand strength, market opportunity, and sales strategy.

3195 Generation Path Co., Ltd.
2026/08/08
Notice Regarding Monthly Sales Performance Compared to the Same Month of the Previous Year for May 2026

Aiming to expand D2C products with growth in the EC marketing business and gross margin improvement, although large deals declined due to AI diffusion, reducing segment profit in EC marketing. Conversely, the product planning-related business achieved substantial growth in revenue and profit driven by contributions from Chinese and Vietnamese subsidiaries. Consolidated operating profit increased significantly, and ordinary profit also rose....

6551 Tsunagu Group Holdings, Inc.
2026/08/08
Q&A Summary for the Second Quarter (Midterm) Financial Results for the Fiscal Year Ending September 2026

While sales decline versus the previous year, growth areas such as OMR and circular hiring are expanding. Expansion of alumni support deployment is progressing, but it takes time for on-site penetration. Demand for foreign worker活躍 support is increasing, but strengthening supply capacity is an issue. The staffing business aims to return to profitability. Shareholder benefit conditions require 500 shares or...

8750 Daiichi Life Group Co., Ltd.
2026/08/07
Q1 FY2027 Financial Summary (Japan GAAP, Consolidated)

Consolidated results for the first quarter of the fiscal year ending March 2027 were disclosed. YoY changes for revenue and profit are unknown. However, key indicators are disclosed in the PDF within the "Financial Summary" section. Details by segment and financial items are shown in the respective tables.

7096 Stem Cell Research Institute Co., Ltd.
2026/08/06
Financial Summary for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated)

Discloses the consolidated results for the first quarter of the fiscal year ending March 2027. Provides trends in revenue and profits, segment-by-segment status, and changes in financial position. The accounting period is from April 1, 2026 to June 30, 2026; major figures are unknown. Future performance outlook is described in the disclosure material.

9853 Ginza Norinora Co., Ltd.
2026/08/06
Q1 2027 Fiscal Year Consolidated Financial Results (Japan GAAP) (Consolidated)

Consolidated results for the first quarter of the fiscal year ending March 2027 were announced. Revenue 2,062,485 thousand yen, operating profit 79,798 thousand yen, net income attributable to owners of parent 86,973 thousand yen, etc., with YoY changes disclosed for each quarterly item. Balance sheet shows total assets 2,366,840 thousand yen in current assets, total liabilities 2,244,864 thousand yen, net...

6776 天昇電気工業株式会社
2026/08/06
2027 fiscal year Q1 Consolidated Financial Results Summary (Japanese GAAP) (Interim)

For the first quarter of fiscal year 2027, consolidated net sales were 5,620,000,000 yen, up 12.7% YoY; operating income was 289,000,000 yen, up 346.3% YoY; ordinary income was 274,000,000 yen, up 88.2% YoY; quarterly net income attributable to owners of parents was 174,000,000 yen, down 21.2% YoY. By segment, Japan Molding-related sales were 5,393,000,000 yen with a profit of 220,000,000...

3374 Uchi-soto Tech Co., Ltd.
2026/08/05
Notice Regarding the Kumamoto Earthquake Impact (Second Report)

Regarding the Kumamoto earthquake impact, there were no human casualties; Kumamoto Sales Office, Kyushu Logistics Center, and Uchi-soto Electronics Kumamoto Services Center have resumed normal operations. The impact on damages and performance is expected to be minor, and if significant effects are anticipated, they will be announced promptly.

3941 Rengo Co., Ltd.
2026/08/05
Notice Regarding Share Buyback Status

Total shares acquired: 2,496,700 shares, total amount: 3,608,748,242 yen, acquisition period: July 1, 2026 to July 31, 2026, method: market purchase. The upper limit for the total number of listed shares is 25,000,000 shares (10.1%), cumulative acquisitions: 6,071,300 shares, total amount: 8,620,302,050 yen.

1 2 3 404
Scroll to Top